Biotech companies in the United States by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Exelixis has the lowest figure of the 7 biotech companies in the United States ranked by P/E ratio, at 19.4, followed by Neurocrine Biosciences (22.3) and Halozyme Therapeutics (22.8). Figures as of 20 Nov 2026, 21:22 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
7
Lowest
Exelixis19.4
Median
25.3
Combined market value
SGD 938.9B
Countries
1
Not ranked
13no P/E ratio on file

Market values as of .

United States
All sectors
Biotech
SGD
Clear filters
Biotech companies in the United States by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ExelixisEXEL · Health Care19.4SGD 20.3BSGD 83.39 1.82% down 55% up United States
2Neurocrine BiosciencesNBIX · Health Care22.3SGD 19.7BSGD 194.28 3.84% down 10% up United States
3Halozyme TherapeuticsHALO · Health Care22.8SGD 13.4BSGD 117.87 1.82% down 32% up United States
4AmgenAMGN · Health Care25.3SGD 304BSGD 562.10 0.15% down 30% up United States
5Krystal BiotechKRYS · Health Care42.0SGD 11.8BSGD 398.56 2.19% down 49% up United States
6Bio-TechneTECH · Health Care66.7SGD 14.7BSGD 93.77 0.04% down 18% up United States
7BiogenBIIB · Health Care108SGD 47.6BSGD 322.04 1.00% up 41% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2903 SGD). 13 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/E ratio?

Exelixis (19.4), Neurocrine Biosciences (22.3) and Halozyme Therapeutics (22.8) have the lowest P/E ratio of the 7 biotech companies in the United States ranked here as of 20 Nov 2026, 21:22 UTC.

How many biotech companies in the United States are in this ranking?

7 are ranked by P/E ratio. 13 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 7 biotech companies in the United States ranked by P/E ratio have a combined market value of SGD 938.9B as of 20 Nov 2026, 21:22 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Biotech companies in the United States by P/E ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.